Clinical Trial Update: Human Leukocyte Antigen (HLA)-Haploidentical Hematopoietic Stem Cell Transplantation for Patients With Aplastic Anemia [Phase 1, Phase 2]

View source ↗

Summary

A completed Phase 1/2 clinical trial evaluated HLA-haploidentical hematopoietic stem cell transplantation in patients with aplastic anemia.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Aplastic Anemia

Drugs mentioned

• HLA-Haploidentical hematopoietic stem cell transplantation

Snippet

Sponsor: Asan Medical Center | Conditions: Aplastic Anemia | Phase 1, Phase 2 | Status: COMPLETED